Fostamatinib Fails to Improve Outcomes in Hypoxemic COVID Patients

Source link : https://www.yourblogdomain.com/2024/12/06/fostamatinib-fails-to-improve-outcomes-in-hypoxemic-covid-patients/

Source link : https://www.newshealth.biz/health-news/fostamatinib-fails-to-improve-outcomes-in-hypoxemic-covid-patients/ The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, according to a phase III trial published in JAMA Network Open. In this exclusive MedPage Today video, Sean P. Collins, MD, MSc, of Vanderbilt University Medical Center in Nashville, Tennessee, discusses the implications […]

Author : yourblogdomain

Publish date : 2024-12-06 17:07:56

Copyright for syndicated content belongs to the linked Source.